BBCNEWS Click - Short Edition June 4, 2024 22:56:00
So here, for example, i can see that the ai risk is low — it's a low—risk patient. some cancer experts see real promise in al tools like owkin's, but there are still challenges. it's really exciting - work and it's showing where the future lies for pathology. while it might not be absolutely. there yet for clinical deployment, i think it's a really important first step, and something. that we should be encouraged by. the real benefit to patients of these is patient safety . in the first instance — _ to make sure that we don't miss cancers, that we can detect small. areas of cancer that c...
Source: archive.org